Annals of the Rheumatic Diseases Published Online First: 05 June 2019. doi: 10.1136/annrheumdis-2019-215315 Hahn BH, McMahon MA, Wilkinson A, et al. See slide deck Read recommendation Lay summary, Bernhard Hellmich, Ana Agueda, Sara Monti, Frank Buttgereit, Hubert de Boysson, Elisabeth Brouwer, Rebecca Cassie, Maria Cinta Cid, Bhaskar Dasgupta, Christian Dejaco, Gulen Hatemi, Nicole Hollinger, Alfred Mahr, Susan P Mollan, Chetan Mukhtyar, Cristina Ponte Carlo Salvarani, Rajappa Sivakumar, Xinping Tian, ​​Gunnar Tomasson, Carl Turesson, Wofgang Schmidt, Peter M Villiger, Richard Watts, Chris Young, Raashid Ahmed Luqmani  Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease affecting multiple organ systems that runs an unpredictable course and may present with a wide variety of clinical manifestations. Annals of the Rheumatic Diseases 2012;71:1771-1782 EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis Cutaneous lupus erythematosus is classified into acute, subacute, chronic and intermittent lupus erythematosus [11, 12]. Published online first: 28 August 2018 The medications most commonly used to control lupus include: 1. See Lay Summary, Maria G Tektonidou, Laura Andreoli, Marteen Limper, Zahir Amoura, Ricard Cervera, Nathalie Costedoat-Chalumeau, Maria Jose Cuadrado, Thomas Dörner, Raquel Ferrer-Oliveras, Karen Hambly, Munther A Khamashta, Judith King, Francesca Marchiori, Pier Luigi Meroni, Marta Mosca, Vittorio Pengo, Luigi Raio, Guillermo Ruiz-Irastorza, Yehuda Shoenfeld, Lyudmila Stojanovich, Elisabet Svenungsson, Denis Wahl, Angela Tincani, Michael M Ward 2016 Update of EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease modifying antirheumatic drugs Whitney J. Palmer. Published online first: 6 April 2018 EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice 2019 update of the EULAR recommendations for the ... Clinical practice guidelines for the treatment of systemic lupus erythematosus external link opens in a new window. Read recommendation Current clinical management of COVID-19 consists of infection prevention and control measures and supportive care, including supplemental oxygen and mechanical ventilatory support when indicated. A team led by Dr. Timothy Niewold of NYU School of Medicine found that a version of the gene PNP found in 20% to 30% of the population may promote high interferon levels. Part II: Management Read recommendation, B. Combe, R. Landewe, C. I Daien, Ch. These microbes release protein fibers called curli that can trap DNA and stimulate the immune system. April 11, 2019. EULAR has issued new treatment guidelines for antiphospholipid syndrome, a disorder of the immune system that causes blood clots. See slide deck, Antonis Fanouriakis, Myrto Kostopoulou, Kim Cheema, Hans-Joachim Anders, Martin Aringer, Ingeborg Bajema, John Boletis, Eleni Frangou, Frederic A Houssiau, Jane Hollis, Adexandre Karras, Francesca Marchiori, Stephen D Marks, Gabriella Moroni, Marta Mosca, Ioannis Parodis, Manuel Praga, Matthias Schneider, Josef S Smolen, Vladimir Tesar, Maria Trachana, Ronald F van Vollenhoven, Alexandre E Voskuyl, Y K Onno Teng, Bernadette van Leew, George Bertsias, David Jayne, Dimitrios T Boumpas Lay summary, Désirée van der Heijde, Sofia Ramiro, Robert Landewé, Xenofon Baraliakos, Filip Van den Bosch, Alexandre Sepriano, Andrea Regel, Adrian Ciurea, Hanne Dagfinrud, Maxime Dougados, Floris van Gaalen, Pál Géher, Irene van der Horst-Bruinsma, Robert D Inman, Merryn Jongkees, Uta Kiltz, Tore K Kvien, Pedro M Machado, Helena Marzo-Ortega, Anna Molto, Victoria Navarro-Compàn, Salih Ozgocmen, Fernando M Pimentel-Santos, John Reveille, Martin Rudwaleit, Jochen Sieper, Percival Sampaio-Barros, Dieter Wiek, Jürgen Braun J Pharmacol Pharmacother. 275 Madison Avenue, 10th Floor, New York, NY 10016. S Smolen, D. Skingle, Z. Szekanecz, T K Kvien, A van der Helm-van Mil, R van Vollenhoven EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis Lay summary It is a chronic condition that can affect multiple tissues and organs. “Luckily, my medication worked better than imagined. Dubey AK, Handu SS, Dubey S, et al. First published December 15, 2016                                                                                             See slide deck                                                                                                                             Read recommendation, P Richette, M Doherty, E Pascual, V Barskova, F Becce, J Castañeda-Sanabria, M Coyfish, S Guillo, T L Jansen, H Janssens, F Lioté, C Mallen, G Nuki, F Perez-Ruiz, J Pimentao, L Punzi, T Pywell, A So, A K Tausche, T Uhlig, J Zavada, W Zhang, F Tubach, T Bardin Annals of the Rheumatic Diseases  doi: 10.1136/annrheumdis-2018-214755 EULAR recommendations for a core data set for pregnancy registries in rheumatology They discovered that in animals with lupus, lymphatic circulation slows down, which may explain why patients with the disease often develop severe skin inflammation. Treatment in SLE aims at remission or low disease activity and prevention of flares. treatment in patients with lupus nephritis has not been as thoroughly examined. F +41 44 716 30 39 EULAR Points to consider for monitoring (detection/prevention) comorbidities in inflammatory rheumatic diseases Nonetheless, most of them are not designed for the Mexican population or are devoted only to the treatment of certain disease manifestations, like lupus nephritis, or are designed for some physiological state like pregnancy. Lupus May Impair the Lymphatic System Ann Rheum Dis doi:10.1136/annrheumdis-2016-209775 New: 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus . Clinical Practice Guidelines Systemic Lupus Erythematosus Search this Guide Search. Read recommendation, Christian Dejaco, Sofia Ramiro, Christina Duftner, Florent L Besson, Thorsten A Bley, Daniel Blockmans, Elisabeth Brouwer, Marco A Cimmino, Eric Clark, Bhaskar Dasgupta, Andreas P Diamantopoulos, Haner Direskeneli, Annamaria Iagnocco, Thorsetn Klink, Lorna Neill, Christina Ponte, Carlo Salvarani, Riemer H J A Slart, Madeline Whitlock, Wolfgang A Schmidt Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that causes inflammation in connective tissues, such as cartilage and the lining of blood vessels, which provide … Symptoms involving the brain and nervous system are not always due to lupus. Published by: Mexican College of Rheumatology. Published Online First: 21 March 2019 First-line treatment of significant lupus thrombocytopaenia (platelet count below 30 000/mm 3) consists of moderate/high doses of GC in combination with IS agent (AZA, MMF or cyclosporine; the latter having the least potential for myelotoxicity) to facilitate GC-sparing. The clinical guideline is accredited by the National Institute for Health and Care Excellence (NICE).. Lupus affects nearly 1 in 1,000 people in the UK, a large proportion of whom are female. Since the original guidelines were published in 2008, followed by subsequent publication of specific recommendations for neuropsychiatric and renal disease, monitoring, and women’s health, “new data have emerged on treatment … Belimumab: first targeted biological treatment for systemic lupus erythematosus. T +41 44 716 30 30 ABSTRACT: Systemic lupus erythematosus (SLE) is an autoimmune disease presenting with varying degrees of organ and system involvement. The bacteria that cause urinary tract infections may trigger lupus flares, a former Alzheimer’s disease therapy has shown promising results in research models—these are just some of the findings presented by Lupus Research Alliance-funded scientists at the 13th International Congress on Systematic Lupus Erythematosus (LUPUS 2019), held in San Francisco. The treatment and management recommendations in these guidelines are based on scientific evidence and expert opinion and are frequently updated. Lay summary Ann Rheum Dis 2011;70:896-904 doi:10.1136/ard.2011.151027  Read this recommendation, Alexandra N Colebatch, Christopher John Edwards, Mikkel Østergaard, Désirée van der Heijde, Peter V Balint, Maria-Antonietta D'Agostino, Kristina Forslind, Walter Grassi, Espen A Haavardsholm, Glenn Haugeberg, Anne-Grethe Jurik, Robert BM Landewé, Esperanza Naredo, Philip J OConnor, Ben Ostendorf, Kristina Poto ki, Wolfgang A Schmidt, Josef S Smolen, Sekib Sokolovic, Iain Watt, Philip G Conaghan Based on emerging new evidence and expert consensus, a task force put together by the European League Against Rheumatism (EULAR) released updated recommendations for the management of systemic lupus erythematosus (SLE). 2019 EULAR Guidelines on Antiphospholipid Syndrome Management Save. EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors Calabrese, X. Mariette, T. Schaeverbeke Guidelines for Screening, Treatment, and Management of Lupus Nephritis. Treatment in SLE aims at remission or low disease activity and prevention of flares. Read Recommendation Annals of the Rheumatic Diseases Published Online First: 31 October 2019. doi: 10.1136/annrheumdis-2019-216114 Lay summary, Linda Fernandes, Kåre B Hagen, Johannes W J Bijlsma, Oyvor Andreassen, Pia Christensen, Philip G Conaghan, Michael Doherty, Rinie Geenen, Alison Hammond, Ingvild Kjeken1, L Stefan Lohmander, Hans Lund, Christian D Mallen, Tiziana Nava, Susan Oliver, Karel Pavelka, Irene Pitsillidou, José Antonio da Silva, Jenny de la Torre, Gustavo Zanoli, Theodora P M Vliet Vlieland United Rheumatology Clinical Practice Guideline Systemic Lupus Erythematosus (SLE) V1.1.2019 34. Annals of the Rheumatic Diseases Published Online First: 22 January, 2020 doi: 10.1136/annrheumdis-2019-216655 ... 10 most important contemporary challenges in the managaement of SLE" Lupus Sci Med 2019; ... to our sites are guided by the Web Content Accessibility Guidelines … Annals of the Rheumatic Diseases Published Online First: 05 June 2020. doi: 10.1136/annrheumdis-2020-217877 In patients with the disease, mitochondria, the structures that serve as power plants for cells, malfunction. Slide deck, W F Lems, K E Dreinhöfer, H Bischoff-Ferrari, M Blauth, E Czerwinski, JAP da Silva, A Herrera, P Hoffmeyer, T Kvien, G Maalouf, D Marsh, J Puget*, W Puhl, G Poor, L Rasch, C Roux, S Schüler, B Seriolo, U Tarantino, T van Geel, A Woolf, C Wyers, P Geusens EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome Their study indicates that bacteria responsible for urinary tract infections may spark flares or even trigger lupus. Points to consider for the development, evaluation and implementation of mobile health applications for self-management in patients with rheumatic diseases ... managing cardiovascular and venous thrombosis risk factors, patient education about treatment adherence, and lifestyle counselling. To summarize, the new guidelines recommend the following: “Treatment in SLE aims at remission or low disease activity and prevention of flares. Read recommendation See slide deck, Margreet Kloppenburg, Féline PB Kroon, Francisco J Blanco, Michael Doherty, Krysia S Dziedzic, Elsie Greibrokk, Ida K Haugen, Gabriel Herrero-Beaumont, Helgi Jonsson, Ingvild Kjeken, Emmanuel Maheu, Roberta Ramonda, Marco JPF Ritt, Wilma Smeets, Josef S Smolen, Tanja A Stamm, Zoltan Szekanecz, Ruth Wittoek, Loreto Carmona A G Semb, G D Kitas, Y M Smulders, Z Szekanecz, N Sattar, D P M Symmons, Each authors lists the following: The authors, the title, the publication citation, publication date and link to the final, published recommendation text. The Accelerating Medicines Partnership enabled Rao and his colleagues to profile the immune cells in kidney tissue samples from more than a dozen medical centers around the United States. Cope, O. Lambotte, J.E. MD Open 2019; 5: e000924. Treating patients with antibiotics to kill the bacteria that cause urinary tract infections may prevent flares, the researchers concluded. Profiling Immune Cells in the Kidneys See slide deck A charitable organization with 501(c)(3) tax-exempt status. Antimalarial therapy compared with no antimalarial therapy effect on all-cause mortality is uncertain because the certainty of the evidence is very low. Advances in treatment over the last decades, such as use of corticosteroids and conventional immunosuppressive drugs, have improved life expectancy of SLE sufferers. And of those with lupus, antibodies that recognize curli were more abundant in people who were undergoing flares. © 2020 Lupus Research Alliance. Screening criteria for systematic review topics of nontreatment and treatment 248 Table 33. When these do not control the disease, immunosuppressives or biologics can be used 7. By the age of 21, I weaned off my meds and put lupus in remission. Their work was part of the Accelerating Medicines Partnership, which the LRA co-sponsors. See slide deck Lay summary, Josef S Smolen, Robert Landewé, Ferdinand C Breedveld, Maya Buch, Gerd Burmester, Maxime Dougados, Paul Emery, Cécile Gaujoux-Viala, Laure Gossec, Jackie Nam, Sofia Ramiro, Kevin Winthrop, Maarten de Wit, Daniel Aletaha, Neil Betteridge, Johannes W J Bijlsma, Maarten Boers, Frank Buttgereit, Bernard Combe, Maurizio Cutolo, Nemanja Damjanov, Johanna M W Hazes, Marios Kouloumas, Tore K Kvien, Xavier Mariette, Karel Pavelka, Piet L C M van Riel, Andrea Rubbert-Roth, Marieke Scholte-Voshaar, David L Scott, Tuulikki Sokka-Isler, John B Wong, Désirée van der Heijde M T Nurmohamed Annals of the Rheumatic Diseases Published Online First: 15 May 2019. doi: 10.1136 / annrheumdis-2019-215213  Read SLR's, G Sakellariou, PG Conaghan, W Zhang, JWJ Bijlsma, P Boyesen, M A D'Agostino, M Doherty, D Fodor, M  Kloppenburg, F Miese, E Naredo, M Porcheret, A Iagnocco First published December 22, 2016 peripheral joint osteoarthritis One multi-ethnic (2) cohort study reported a possible decrease in ≥50% On Friday 6 th October 2017, during Lupus Awareness Month, the British Society for Rheumatology (BSR) published the first UK guideline on the care of adults with systemic lupus erythematosus (lupus). First published September 13, 2019, RMD Open 2019;5:e001014. Read recommendation The investigators performed a systematic review of studies focused on treatment … First published July 31, 2012 European League Against Rheumatism, EULAR has released its 2019 guidelines and recommendations for the management of systemic lupus erythematosus (SLE).They have appeared in Annals of Rheumatic Diseases. Close monitoring of disease activity and patient adherence to treatment are recommended to help reduce the risk for flare. Goals for the treatment of SLE should aim to target remission of disease symptoms, prevention of damage from disease activity, minimization of drug side-effects, and improvement of quality of life measures. Dr. Caricchio and his colleagues discovered that curli worsen lupus symptoms in animal models. reach consensus. Lay summary, MW Heijstek, L M Ott de Bruin, M Bijl, R Borrow, F van der Klis, i Koné-Paut, A Fasth, K Minden, A Ravelli, M Abinun, G S Pileggi, M Borte, N M Wulffraat April 11, 2019. Read this recommendation, L Gossec, J S Smolen, C Gaujoux-Viala, Z Ash, H Marzo-Ortega, D van der Heijde, O FitzGerald, D Aletaha, P Balint, D Boumpas, J Braun, F C Breedveld, G Burmester, J D Cañete, M de Wit, H Dagfinrud, K de Vlam, M Dougados, P Helliwell, A Kavanaugh, T K Kvien, R Landewé, T Luger, M Maccarone, D McGonagle, N McHugh, I B McInnes, C Ritchlin, J Sieper, P P Tak, G Valesini, J Vencovsky, K L Winthrop, A Zink, P Emery The drug, idebenone, was not effective against Alzheimer’s disease. For instance, they identified three varieties of the cell-killers known as cytotoxic T cells, which suggests each type may have a different role in lupus nephritis. Read recommendation EULAR has issued new treatment guidelines for antiphospholipid syndrome, a disorder of the immune system that causes blood clots. 4th April, 2019, Kilchberg, Switzerland The European League Against Rheumatism, EULAR, – has published an update to a set of recommendations . Literature search yield of RCTs 248 Table 34. Annals of the Rheumatic Diseases 2017;76:802-810 EULAR recommendations for vaccination in paediatric patients with rheumatic diseases Among the recommendations, high risk individuals who carry the antiphospholipid antibody should … Ann Rheum Dis doi:10.1136/annrheumdis-2015-208690 Read recommendation, Robert BM Landewé, Pedro M Machado, Féline Kroon, Hans WJ Bijlsma, Gerd R Burmester, Loreto Carmona, Bernard Combe, Massimo Galli, Laure Gossec Annamaria Iagnocco, John D Isaacs, Xavier Mariette, Iain McInnes, Ulf Mueller-Ladner, Peter Openshaw, Josef S Smolen, Tanja A Stamm, Dieter Wiek, Hendrik Schulze-Koops Annals of the Rheumatic Diseases 2017;76:639-646 Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease affecting multiple organ systems that runs an unpredictable course and may present with a wide variety of clinical manifestations. Annals of the Rheumatic Diseases 2018; 10.1136/annrheumdis-2018-213225 medwireNews: EULAR has published up-to-date recommendations for the management of systemic lupus erythematosus (SLE) based on emerging evidence and expert opinion.. Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that causes inflammation in connective tissues, such as cartilage and the lining of blood vessels, … Read SLRs, Pascal Richette, Michael Doherty, Eliseo Pascual, Victoria Barskova, Fabio Becce, Johann castaneda, Malcolm Coyfish, Sylvie Guillo, Tim Jansen, Hein Janssens, Frédéric Lioté, Christian D Mallen, George Nuki, Fernando Perez-Ruiz, José Pimentao, Leonardo Punzi, Anthony Pywel, Alexander K So, Anne-Kathrin Tausche, Till Uhlig, Jakub Zavada, Weiya Zhang, Florence Tubach, Thomas Bardin Published Online First: 13 January 2017 Patients with lupus usually produce too much of the proteins known as type I interferons, which stimulate the immune system. KDIGO GN Guideline update – Evidence summary Lupus nephritis Antimalarial therapy for lupus nephritis PICO question In patients with lupus nephritis, compared to no treatment, placebo or standard of care, does antimalarial therapy improve clinical efficacy (all-cause mortality, end-stage kidney disease, ≥50% Dr. Deepak Rao of Harvard Medical School and colleagues provided a detailed and comprehensive look at the immune cells that invade and damage the kidneys in patients with lupus. EULAR Recommendations for the use of imaging in large vessel vasculitis in clinical practice New Guidelines for Lupus Treatment From EULAR, Updates in Lupus Clinical Research from the LUPUS 2019 Meeting. Read recommendation, Laure Gossec Xenofon Baraliakos, Andreas Kerschbaumer, Maarten de Wit, Iain McInnes, Maxime Dougados, Jette Primdahl, Dennis G McGonagle, Daniel Aletaha, Andra Balanescu, Peter V Balint, Heidi Bertheussen, Wolf-Henning Boehncke, Gerd R Burmester, Juan D Canete, Nemanja S Damjanov, Tue Wenzel Kragstrup, Tore K Kvien, Robert B M Landewé, Rik Jozef Urbain Lories, Helena Marzo-Ortega, Denis Poddubnyy, Santiago Andres Rodrigues Manica, Georg Schett, Douglas J Veale, Filip E Van den Bosch, Désirée van der Heijde, Josef S Smolen Annals of the Rheumatic Diseases Published Online First : August 14, 2019. doi: 10.1136 / annrheumdis-2019 to 215,882 March 25, 2019. Read this recommendation, Y van Eijk-Hustings, A van Tubergen, C Boström, E Braychenko, B Buss, J Felix, J Firth, A Hammond, B Harston, C Hernandez, M Huzjak, J Korandová, M L Kukkurainen, R Landewé, M Mezieres, M Milincovic, A Moretti, S Oliver, J Primdahl, M Scholte-Voshaar, J de la Torre-Aboki, J Waite-Jones, R Westhovens, H Andersen Zangi, T Heiberg, J Hill American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Back to the Pharmacy Guide. EULAR Data Protection Policy, Heidi A Zangi, Mwidimi Ndosi, Jo Adams, Lena Andersen, Christina Bode, Carina Boström, Yvonne van Eijk-Hustings, Laure Gossec, Jana Korandová, Gabriel Mendes, Karin Niedermann, Jette Primdahl, Michaela Stoffer, Marieke Voshaar, Astrid van Tubergen, EULAR Annual European Congress of Rheumatology, Classification and response criteria/diagnostic approaches, Recommendations for conducting/reporting clinical trials, PARE (People with Arthritis and Rheumatism), European Parliament Interest Group on RMDs, Download the EULAR 2016 Congress presentation, Otylia Kowal-Bielecka, Jaap Fransen, Jerome Avouac, Mike Becker, Agnieszka Kulak, Yannick Allanore, Oliver Distler, Philip Clements, Maurizio Cutolo, Laszlo Czirjak, Nemanja Damjanov, Francesco del Galdo, Christopher P Denton, Jörg H W Distler, Ivan Foeldvari, Kim Figelstone, Marc Frerix, Daniel E Furst, Serena Guiducci, Nicolas Hunzelmann, Dinesh Khanna, Marco Matucci-Cerinic, Ariane L Herrick, Frank van den Hoogen, Jacob M van Laar, Gabriela Riemekasten, Richard Silver, Vanessa Smith, Alberto Sulli, Ingo Tarner, Alan Tyndall, Joep Welling, Frederic Wigley, Gabriele Valentini, Ulrich A Walker, Francesco Zulian, Ulf Müller-Ladner, Christian Dejaco, Yogesh P Singh, Pablo Perel, Andrew Hutchings, Dario Camellino, Sarah Mackie, Andy Abril, Artur Bachta, Peter Balint, Kevin Barraclough, Lina Bianconi, Frank Buttgereit, Steven Carsons, Daniel Ching, Maria Cid, Marco Cimmino, Andreas Diamantopoulos, William Docken, Christina Duftner, Billy Fashanu, Kate Gilbert, Pamela Hildreth, Jane Hollywood, David Jayne, Manuella Lima, Ajesh Maharaj, Christian Mallen, Victor Martinez-Taboada, Mehrdad Maz, Steven Merry, Jean Miller, Shunsuke Mori, Lorna Neill, Elisabeth Nordborg, Jennifer Nott, Hannah Padbury, Colin Pease, Carlo Salvarani, Michael Schirmer, Wolfgang Schmidt, Robert Spiera, David Tronnier, Alexandre Wagner, Madeline Whitlock, Eric L Matteson, Bhaskar Dasgupta. Food sources include fish oil, olive oil, flaxseed oil, salmon, tuna, sardines, and herring. Among the recommendations, high risk individuals who carry the antiphospholipid antibody should take low-dose aspirin, even if they are asymptomatic. EULAR recommendations for the management of familial Mediterranean fever Annals of the Rheumatic Diseases 2020;79:778-786. Read recommendation See slide deck Lupus nephritis treatment depends usually on the features found at renal biopsy (Table 3) [27, 28]. With her grant from the Lupus Research Alliance, Dr. Theresa Lu, Dr. Noa Schwartz and other colleagues at the Hospital for Special Surgery performed one of the first studies to identify how lupus changes the lymphatic system, the network of tubes that transports fluid and immune cells around the body. Annals of the Rheumatic Diseases Published Online First: 23 April 2020. doi: 10.1136/annrheumdis-2020-217139 EULAR revised recommendations for the management of fibromyalgia Below are some helpful diet guidelines to support a healthy gut microbiome and reduce inflammation: With a stable disease, a diet rich in polyunsaturated fatty acids and anti-inflammatory omega-3 fatty acids can help prevent inflammation. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read this recommendation, J Braun, R van den Berg, X Baraliakos, H Boehm, R Burgos-Vargas, E Collantes-Estevez, H Dagfinrud, B Dijkmans, M Dougados, P Emery, P Geher, M Hammoudeh, RD Inman, M Jongkees, MA Khan, U Kiltz, TK Kvien, M Leirisalo-Repo, WP Maksymowych, I Olivieri, K Pavelka, J Sieper, E Stanislawska-Biernat, D Wendling, S Özgocem, C van Drogen, BJ van Royen, D Van der Heijde Read recommendation Reviving an Old Drug to Treat Lupus On Friday 6 th October 2017, during Lupus Awareness Month, the British Society for Rheumatology (BSR) published the first UK guideline on the care of adults with systemic lupus erythematosus (lupus).